Month: April 2024

Weight-Loss Drug Zepbound Cuts Sleep Apnea Severity

Eli Lilly says its weight-loss drug helped reduce episodes of irregular breathing associated with a common sleep-related disorder in two late-stage trials, paving the way for expanding use of the drug. The drug cut the frequency of irregular breathing episodes by as much as… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]

Published on April 18, 2024

FDA: Most Mounjaro, Zepbound Doses in Limited Supply

Most doses of Eli Lilly’s diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand, the U.S. Food and Drug Administration’s website showed on Wednesday. Both drugs had limited availability… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]

Published on April 18, 2024

Two-Drug Combo Effective Against Severe Alcoholism

A combo of an allergy drug and a blood pressure med appears to lower daily drinking in folks battling severe alcoholism, French researchers report. The two generic drugs are the antihistamine cyproheptadine and prazosin, which treats high blood pressure and urinary urgency,… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on April 18, 2024